APO Research
Talk to an analyst

APO RESEARCH · REPORT

Manufacturing Execution Systems for Pharma and Biotech

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Manufacturing Execution Systems for Pharma and Biotech Industry Growth and Trends Forecast to 2032

1 January 2026112 pages

Choose your research edition.

Industry ResearchManufacturing Execution Systems for Pharma and Biotech Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Manufacturing Execution Systems for Pharma and Biotech Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Manufacturing Execution Systems for Pharma and Biotech Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Manufacturing Execution Systems for Pharma and Biotech Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Manufacturing Execution Systems for Pharma and Biotech Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

According to APO Research, the global Manufacturing Execution Systems for Pharma and Biotech market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Manufacturing Execution Systems for Pharma and Biotech is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Manufacturing Execution Systems for Pharma and Biotech is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Manufacturing Execution Systems for Pharma and Biotech is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Manufacturing Execution Systems for Pharma and Biotech market include Lonza, Vimachem, Korber, MasterControl, POMS Corporation, AspenTech, GE Vernova, 凯睿德 and Dassault Systemes, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Manufacturing Execution Systems for Pharma and Biotech market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Manufacturing Execution Systems for Pharma and Biotech market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Manufacturing Execution Systems for Pharma and Biotech market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Manufacturing Execution Systems for Pharma and Biotech.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Manufacturing Execution Systems for Pharma and Biotech market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Manufacturing Execution Systems for Pharma and Biotech Market by Company

Lonza

Vimachem

Korber

MasterControl

POMS Corporation

AspenTech

GE Vernova

凯睿德

Dassault Systemes

IBM

Rockwell Automation

ABB

Accevo Systems

AmpleLogic

Siemens Software

NNIT

Metronik

Tulip

Manufacturing Execution Systems for Pharma and Biotech Segment by Type

Cloud-based

On-premises

Manufacturing Execution Systems for Pharma and Biotech Segment by Application

Large Enterprises

SMEs

Manufacturing Execution Systems for Pharma and Biotech Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Manufacturing Execution Systems for Pharma and Biotech market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Manufacturing Execution Systems for Pharma and Biotech and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Manufacturing Execution Systems for Pharma and Biotech.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Manufacturing Execution Systems for Pharma and Biotech companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Manufacturing Execution Systems for Pharma and Biotech Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Region (2021-2026) Table 4. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Region (2027-2032) Table 6. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Type (2021-2026) Table 9. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Share Forecasted by Type (2027-2032) Table 11. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Application (2021-2026) Table 24. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Share Forecasted by Application (2027-2032) Table 26. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Manufacturing Execution Systems for Pharma and Biotech Industry Trends Table 37. Manufacturing Execution Systems for Pharma and Biotech Industry Drivers Table 38. Manufacturing Execution Systems for Pharma and Biotech Industry Opportunities and Challenges Table 39. Manufacturing Execution Systems for Pharma and Biotech Industry Restraints Table 40. Global Manufacturing Execution Systems for Pharma and Biotech Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Manufacturing Execution Systems for Pharma and Biotech Revenue Market Share by Company (2021-2026) Table 42. Global Manufacturing Execution Systems for Pharma and Biotech Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Manufacturing Execution Systems for Pharma and Biotech Key Company Headquarters & Area Served Table 44. Global Manufacturing Execution Systems for Pharma and Biotech Company, Product Type & Application Table 45. Global Manufacturing Execution Systems for Pharma and Biotech Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Manufacturing Execution Systems for Pharma and Biotech by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza Company Information Table 49. Lonza Business Overview Table 50. Lonza Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 52. Lonza Recent Development Table 53. Vimachem Company Information Table 54. Vimachem Business Overview Table 55. Vimachem Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Vimachem Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 57. Vimachem Recent Development Table 58. Korber Company Information Table 59. Korber Business Overview Table 60. Korber Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Korber Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 62. Korber Recent Development Table 63. MasterControl Company Information Table 64. MasterControl Business Overview Table 65. MasterControl Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. MasterControl Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 67. MasterControl Recent Development Table 68. POMS Corporation Company Information Table 69. POMS Corporation Business Overview Table 70. POMS Corporation Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. POMS Corporation Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 72. POMS Corporation Recent Development Table 73. AspenTech Company Information Table 74. AspenTech Business Overview Table 75. AspenTech Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. AspenTech Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 77. AspenTech Recent Development Table 78. GE Vernova Company Information Table 79. GE Vernova Business Overview Table 80. GE Vernova Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GE Vernova Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 82. GE Vernova Recent Development Table 83. 凯睿德 Company Information Table 84. 凯睿德 Business Overview Table 85. 凯睿德 Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. 凯睿德 Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 87. 凯睿德 Recent Development Table 88. Dassault Systemes Company Information Table 89. Dassault Systemes Business Overview Table 90. Dassault Systemes Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Dassault Systemes Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 92. Dassault Systemes Recent Development Table 93. IBM Company Information Table 94. IBM Business Overview Table 95. IBM Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. IBM Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 97. IBM Recent Development Table 98. Rockwell Automation Company Information Table 99. Rockwell Automation Business Overview Table 100. Rockwell Automation Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Rockwell Automation Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 102. Rockwell Automation Recent Development Table 103. ABB Company Information Table 104. ABB Business Overview Table 105. ABB Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. ABB Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 107. ABB Recent Development Table 108. Accevo Systems Company Information Table 109. Accevo Systems Business Overview Table 110. Accevo Systems Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Accevo Systems Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 112. Accevo Systems Recent Development Table 113. AmpleLogic Company Information Table 114. AmpleLogic Business Overview Table 115. AmpleLogic Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AmpleLogic Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 117. AmpleLogic Recent Development Table 118. Siemens Software Company Information Table 119. Siemens Software Business Overview Table 120. Siemens Software Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Siemens Software Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 122. Siemens Software Recent Development Table 123. NNIT Company Information Table 124. NNIT Business Overview Table 125. NNIT Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. NNIT Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 127. NNIT Recent Development Table 128. Metronik Company Information Table 129. Metronik Business Overview Table 130. Metronik Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Metronik Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 132. Metronik Recent Development Table 133. Tulip Company Information Table 134. Tulip Business Overview Table 135. Tulip Manufacturing Execution Systems for Pharma and Biotech Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Tulip Manufacturing Execution Systems for Pharma and Biotech Product Portfolio Table 137. Tulip Recent Development Table 138. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2026) Table 141. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Manufacturing Execution Systems for Pharma and Biotech Market Share Forecast by Country (2027-2032) Table 143. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2026) Table 146. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Manufacturing Execution Systems for Pharma and Biotech Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2026) Table 151. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Share Forecast by Country (2027-2032) Table 153. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2026) Table 156. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2026) Table 161. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Manufacturing Execution Systems for Pharma and Biotech Product Image Figure 3. Global Manufacturing Execution Systems for Pharma and Biotech Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Manufacturing Execution Systems for Pharma and Biotech Market Size (2021-2032) & (US$ Million) Figure 5. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Region: 2025 VS 2032 Figure 6. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Region (2021-2032) Figure 7. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cloud-based Image Figure 13. Global Cloud-based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. On-premises Image Figure 15. Global On-premises Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Type 2025 VS 2032 Figure 18. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Type (2021-2032) Figure 19. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Type (2021-2032) Figure 21. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Type (2021-2032) Figure 23. Large Enterprises Image Figure 24. Global Large Enterprises Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. SMEs Image Figure 26. Global SMEs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Application 2025 VS 2032 Figure 29. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Application (2021-2032) Figure 30. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Application (2021-2032) Figure 32. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Manufacturing Execution Systems for Pharma and Biotech Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2032) Figure 39. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Manufacturing Execution Systems for Pharma and Biotech Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2032) Figure 42. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2032) Figure 45. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2032) Figure 48. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premises
Applications
  • Large Enterprises
  • SMEs
Companies covered
  • Lonza
  • Vimachem
  • Korber
  • MasterControl
  • POMS Corporation
  • AspenTech
  • GE Vernova
  • 凯睿德
  • Dassault Systemes
  • IBM
  • Rockwell Automation
  • ABB
  • Accevo Systems
  • AmpleLogic
  • Siemens Software
  • NNIT
  • Metronik
  • Tulip

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2021-2032)
  5. 1.4.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2021-2026)
  6. 1.4.2 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2027-2032)
  7. 1.5 Key Regions Manufacturing Execution Systems for Pharma and Biotech Market Size (2021-2032)
  8. 1.5.1 North America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (2021-2032)
2 Manufacturing Execution Systems for Pharma and Biotech Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cloud-based
  3. 2.1.2 On-premises
  4. 2.2 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Type
  5. 2.2.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Manufacturing Execution Systems for Pharma and Biotech Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Regions
  9. 2.3.1 North America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Type (2021-2026)
3 Manufacturing Execution Systems for Pharma and Biotech Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Large Enterprises
  3. 3.1.2 SMEs
  4. 3.2 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Application
  5. 3.2.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Manufacturing Execution Systems for Pharma and Biotech Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Regions
  9. 3.3.1 North America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Manufacturing Execution Systems for Pharma and Biotech Industry Trends
  2. 4.2 Manufacturing Execution Systems for Pharma and Biotech Industry Drivers
  3. 4.3 Manufacturing Execution Systems for Pharma and Biotech Industry Opportunities and Challenges
  4. 4.4 Manufacturing Execution Systems for Pharma and Biotech Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Manufacturing Execution Systems for Pharma and Biotech Revenue (2021-2026)
  2. 5.2 Global Manufacturing Execution Systems for Pharma and Biotech Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Manufacturing Execution Systems for Pharma and Biotech Key Company Headquarters & Area Served
  4. 5.4 Global Manufacturing Execution Systems for Pharma and Biotech Company, Product Type & Application
  5. 5.5 Global Manufacturing Execution Systems for Pharma and Biotech Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Manufacturing Execution Systems for Pharma and Biotech Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Manufacturing Execution Systems for Pharma and Biotech Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Manufacturing Execution Systems for Pharma and Biotech Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 Vimachem
  8. 6.2.1 Vimachem Company Information
  9. 6.2.2 Vimachem Business Overview
  10. 6.2.3 Vimachem Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Vimachem Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  12. 6.2.5 Vimachem Recent Developments
  13. 6.3 Korber
  14. 6.3.1 Korber Company Information
  15. 6.3.2 Korber Business Overview
  16. 6.3.3 Korber Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Korber Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  18. 6.3.5 Korber Recent Developments
  19. 6.4 MasterControl
  20. 6.4.1 MasterControl Company Information
  21. 6.4.2 MasterControl Business Overview
  22. 6.4.3 MasterControl Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 MasterControl Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  24. 6.4.5 MasterControl Recent Developments
  25. 6.5 POMS Corporation
  26. 6.5.1 POMS Corporation Company Information
  27. 6.5.2 POMS Corporation Business Overview
  28. 6.5.3 POMS Corporation Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 POMS Corporation Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  30. 6.5.5 POMS Corporation Recent Developments
  31. 6.6 AspenTech
  32. 6.6.1 AspenTech Company Information
  33. 6.6.2 AspenTech Business Overview
  34. 6.6.3 AspenTech Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 AspenTech Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  36. 6.6.5 AspenTech Recent Developments
  37. 6.7 GE Vernova
  38. 6.7.1 GE Vernova Company Information
  39. 6.7.2 GE Vernova Business Overview
  40. 6.7.3 GE Vernova Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GE Vernova Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  42. 6.7.5 GE Vernova Recent Developments
  43. 6.8 凯睿德
  44. 6.8.1 凯睿德 Company Information
  45. 6.8.2 凯睿德 Business Overview
  46. 6.8.3 凯睿德 Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 凯睿德 Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  48. 6.8.5 凯睿德 Recent Developments
  49. 6.9 Dassault Systemes
  50. 6.9.1 Dassault Systemes Company Information
  51. 6.9.2 Dassault Systemes Business Overview
  52. 6.9.3 Dassault Systemes Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Dassault Systemes Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  54. 6.9.5 Dassault Systemes Recent Developments
  55. 6.10 IBM
  56. 6.10.1 IBM Company Information
  57. 6.10.2 IBM Business Overview
  58. 6.10.3 IBM Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 IBM Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  60. 6.10.5 IBM Recent Developments
  61. 6.11 Rockwell Automation
  62. 6.11.1 Rockwell Automation Company Information
  63. 6.11.2 Rockwell Automation Business Overview
  64. 6.11.3 Rockwell Automation Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Rockwell Automation Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  66. 6.11.5 Rockwell Automation Recent Developments
  67. 6.12 ABB
  68. 6.12.1 ABB Company Information
  69. 6.12.2 ABB Business Overview
  70. 6.12.3 ABB Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 ABB Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  72. 6.12.5 ABB Recent Developments
  73. 6.13 Accevo Systems
  74. 6.13.1 Accevo Systems Company Information
  75. 6.13.2 Accevo Systems Business Overview
  76. 6.13.3 Accevo Systems Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Accevo Systems Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  78. 6.13.5 Accevo Systems Recent Developments
  79. 6.14 AmpleLogic
  80. 6.14.1 AmpleLogic Company Information
  81. 6.14.2 AmpleLogic Business Overview
  82. 6.14.3 AmpleLogic Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AmpleLogic Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  84. 6.14.5 AmpleLogic Recent Developments
  85. 6.15 Siemens Software
  86. 6.15.1 Siemens Software Company Information
  87. 6.15.2 Siemens Software Business Overview
  88. 6.15.3 Siemens Software Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Siemens Software Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  90. 6.15.5 Siemens Software Recent Developments
  91. 6.16 NNIT
  92. 6.16.1 NNIT Company Information
  93. 6.16.2 NNIT Business Overview
  94. 6.16.3 NNIT Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 NNIT Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  96. 6.16.5 NNIT Recent Developments
  97. 6.17 Metronik
  98. 6.17.1 Metronik Company Information
  99. 6.17.2 Metronik Business Overview
  100. 6.17.3 Metronik Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Metronik Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  102. 6.17.5 Metronik Recent Developments
  103. 6.18 Tulip
  104. 6.18.1 Tulip Company Information
  105. 6.18.2 Tulip Business Overview
  106. 6.18.3 Tulip Manufacturing Execution Systems for Pharma and Biotech Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Tulip Manufacturing Execution Systems for Pharma and Biotech Product Portfolio
  108. 6.18.5 Tulip Recent Developments
7 North America
  1. 7.1 North America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026)
  3. 7.3 North America Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026)
  3. 8.3 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026)
  3. 10.3 South America Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst